Want to see FR:LNA full AI Analyst Report?
Top Page
LNA Sante SA
(LNA)
Select Model
Select Model
Rating:66Neutral
Price Target:
€37.00
▲(51.02% Upside)
Action:Reiterated
Date:07/01/26
Overall score is driven by stable operating fundamentals and strong cash generation, offset by meaningful leverage and thin net profitability. Technicals add support via a clear uptrend above key moving averages, while valuation appears reasonable with a modest dividend yield.
Positive Factors
Cash generation
Consistently positive operating and free cash flow demonstrates durable cash conversion ability. This supports self-funding of maintenance capex and ordinary working capital, enables dividends or targeted reinvestment, and reduces reliance on external financing across multi-quarter cycles.
Negative Factors
High leverage
Debt-to-equity near three times signals substantial financial leverage for a healthcare facilities business. Elevated debt raises refinancing and interest-rate exposure, limits strategic flexibility, and makes the firm more vulnerable to earnings volatility or reimbursement shifts over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Consistently positive operating and free cash flow demonstrates durable cash conversion ability. This supports self-funding of maintenance capex and ordinary working capital, enables dividends or targeted reinvestment, and reduces reliance on external financing across multi-quarter cycles.
Read all positive factors
LNA Sante SA (LNA) vs. iShares MSCI France ETF (EWQ)
Market Cap
€374.08M
Dividend Yield2.73%
Average Volume (3M)3.16K
Price to Earnings (P/E)15.3
Beta (1Y)0.42
Revenue Growth13.15%
EPS Growth10.30%
CountryFR
Employees9,000
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)2.35
Shares Outstanding10,709,416
10 Day Avg. Volume3,290
30 Day Avg. Volume3,156
Financial Highlights & Ratios
PEG Ratio1.01
Price to Book (P/B)0.76
Price to Sales (P/S)0.28
P/FCF Ratio4.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€42.00Price Target Upside71.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.87
Revenue Forecast (FY)€990.04M
LNA Sante SA Business Overview & Revenue Model
Company Description
Established in 1990 and headquartered in Vertou, France, LNA Santé SA specializes in the administration and operation of a diverse portfolio of healthcare facilities. These include residences for the elderly, medical and rehabilitative care center...
How the Company Makes Money
null...
LNA Sante SA Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
44
Neutral
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 912.67M | 806.60M | 736.09M | 728.22M | 689.49M |
| Gross Profit | 132.24M | 91.10M | 241.09M | 622.42M | 577.87M |
| EBITDA | 144.28M | 144.85M | 144.63M | 141.82M | 131.64M |
| Net Income | 24.14M | 21.82M | 23.41M | 25.81M | 23.51M |
Balance Sheet | |||||
| Total Assets | 1.60B | 1.54B | 1.51B | 1.51B | 1.53B |
| Cash, Cash Equivalents and Short-Term Investments | 94.83M | 75.06M | 77.17M | 101.98M | 152.12M |
| Total Debt | 907.25M | 936.51M | 887.67M | 911.55M | 1.00B |
| Total Liabilities | 1.26B | 1.21B | 1.20B | 1.21B | 1.31B |
| Stockholders Equity | 330.25M | 313.81M | 299.24M | 289.33M | 216.09M |
Cash Flow | |||||
| Free Cash Flow | 59.30M | 71.24M | 84.56M | 89.86M | 65.98M |
| Operating Cash Flow | 70.42M | 82.06M | 97.50M | 103.20M | 79.92M |
| Investing Cash Flow | -14.21M | -23.72M | -15.69M | -41.99M | -27.65M |
| Financing Cash Flow | -36.50M | -88.80M | -106.69M | -110.88M | -21.53M |
LNA Sante SA Technical Analysis
Positive
24.50
Price Trends
32.39
Positive
29.52
Positive
26.48
Positive
Market Momentum
0.93
Negative
70.83
Negative
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LNA, the sentiment is Positive. The current price of 24.5 is below the 20-day moving average (MA) of 34.14, below the 50-day MA of 32.39, and below the 200-day MA of 26.48, indicating a bullish trend. The MACD of 0.93 indicates Negative momentum. The RSI at 70.83 is Negative, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LNA.
LNA Sante SA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | €473.00M | 14.52 | 5.18% | 3.95% | 2.78% | 187.96% | |
66 Neutral | €374.08M | 15.28 | 6.64% | 2.73% | 13.15% | 10.30% | |
60 Neutral | €1.20B | -21.60 | -4.36% | ― | 3.51% | 42.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | €2.30B | -7.70 | -13.50% | ― | 4.61% | 30.63% | |
49 Neutral | €173.32M | 5.93 | 3.97% | ― | -11.89% | 1623.56% | |
42 Neutral | €414.95M | -2.70 | -58.93% | ― | -15.98% | -54.34% |
* General Sector Average
FR:LNA
LNA Sante SA
35.90
10.87
43.42%
FR:BLC
Bastide le Confort Medical
23.70
-7.50
-24.04%
FR:BOI
Boiron SA
27.00
5.84
27.63%
FR:EMEIS
Orpea SA
14.25
3.57
33.43%
FR:GDS
Ramsay Generale de Sante
10.85
-0.05
-0.46%
FR:VLA
Valneva
2.19
-0.54
-19.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.